Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring

Sara Capiau, Herman Veenhof, Remco A. Koster, Yngve Bergqvist, Michael Boettcher, Otto Halmingh, Brian G. Keevil, Birgit C. P. Koch, Rafael Linden, Constantinos Pistos, Leo M. Stolk, Daan J. Touw, Christophe P. Stove, Jan-Willem C. Alffenaar*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)409-430
Number of pages22
JournalTherapeutic Drug Monitoring
Volume41
Issue number4
DOIs
Publication statusPublished - Aug 2019

Keywords

  • dried blood spots
  • guideline
  • validation
  • microsampling
  • VAMS
  • HEMATOCRIT-INDEPENDENT RECOVERY
  • LC-MS/MS
  • QUANTITATIVE-DETERMINATION
  • BIOANALYTICAL METHODS
  • MASS-SPECTROMETRY
  • CYCLOSPORINE-A
  • REGRESSION PROCEDURES
  • TRANSPLANT PATIENTS
  • EBF RECOMMENDATION
  • ALTERNATIVE TOOL

Cite this

Capiau, S., Veenhof, H., Koster, R. A., Bergqvist, Y., Boettcher, M., Halmingh, O., Keevil, B. G., Koch, B. C. P., Linden, R., Pistos, C., Stolk, L. M., Touw, D. J., Stove, C. P., & Alffenaar, J-W. C. (2019). Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring. Therapeutic Drug Monitoring, 41(4), 409-430. https://doi.org/10.1097/FTD.0000000000000643